This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Mark Your Calendar to Join Us This Year September 23-26, 2024
Hynes Convention Center in BostonBoston, MA

John Crowley
Executive Chairman at Amicus Therapeutics
Speaker

Profile

John F. Crowley is the Founder and Executive Chairman of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. He served as Chief Executive Officer of Amicus from 2005 to 2022. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his position at Bristol-Myers Squibb and became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children’s lives). In 2001, Novazyme was acquired by Genzyme Corporation and John continued to play a lead role in the development of a drug for Pompe disease as Senior Vice President, Genzyme Therapeutics.

John and his family have been profiled numerous times on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, “The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children.” The 2010 major motion picture, Extraordinary Measures, starring Brendan Fraser, Harrison Ford and Keri Russell, is inspired by the Crowley family journey. John is the author of a personal memoir: “Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy.”

John served as a commissioned officer in the U.S. Navy Reserve from 2005-2016, assigned to the United States Special Operations Command, and is a veteran of the global war on terrorism, with service in Afghanistan.

Agenda Sessions

  • Leading with Passion and Compassion

    4:30pm